Status:
COMPLETED
Patient Comfort During High Flow Nasal Cannula Versus Nasal Continuous Airway Pressure (CPAP)
Lead Sponsor:
University Hospital of North Norway
Conditions:
Respiratory Distress Syndrome, Newborn
Medical Device Discomfort
Eligibility:
All Genders
25-34 years
Phase:
NA
Brief Summary
Preterm children are at increased risk for developing lung disease due to immature lungs. Non-invasive ventilation (NIV) support is increasingly used as treatment. Nasal continuous positive airway pre...
Eligibility Criteria
Inclusion
- Preterm infants admitted to the NICU at University Hospital of North Norway, Tromsoe, Norway (single center study)
- Gestational age (GA) \< 34 weeks
- Corrected age \< 34 weeks
- Receiving nasal CPAP for respiratory distress
- Respiratory "stable": FiO2 \< 30%, pCO2 \< 8,5 kPa and pH \> 7.25.
- GA \< 29 weeks: Respiratory "stable" over last 72 h.
- GA 29-33 weeks: Respiratory "stable" over last 24 h.
Exclusion
- Congenital anomalies
- Ongoing treatment for hypoglycemia or infection
- Other intercurrent disease requiring frequent blood sampling
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01526226
Start Date
February 1 2012
End Date
May 1 2013
Last Update
June 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of North Norway
Tromsø, Norway, N-9038